Venturi Wealth Management LLC Invests $559,000 in Axon Enterprise, Inc $AXON

Venturi Wealth Management LLC purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the second quarter, HoldingsChannel reports. The institutional investor purchased 997 shares of the biotechnology company’s stock, valued at approximately $559,000.

Other institutional investors have also added to or reduced their stakes in the company. Evergreen Capital Management LLC lifted its stake in Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after purchasing an additional 15 shares during the last quarter. Synergy Financial Group LTD increased its holdings in shares of Axon Enterprise by 1.4% during the third quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock worth $996,000 after buying an additional 19 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Axon Enterprise by 1.2% during the second quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company’s stock worth $1,350,000 after buying an additional 19 shares in the last quarter. Certuity LLC boosted its holdings in shares of Axon Enterprise by 5.1% during the 4th quarter. Certuity LLC now owns 474 shares of the biotechnology company’s stock valued at $269,000 after acquiring an additional 23 shares in the last quarter. Finally, Pure Financial Advisors LLC grew its position in Axon Enterprise by 6.7% during the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after acquiring an additional 23 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 5.7%

NASDAQ AXON opened at $599.78 on Thursday. The business has a 50 day simple moving average of $521.48 and a 200 day simple moving average of $473.41. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $794.29. The stock has a market capitalization of $48.73 billion, a P/E ratio of 248.87, a P/E/G ratio of 12.98 and a beta of 1.39. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company’s revenue was up 35.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.12 earnings per share. Research analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Connected Devices remain a key growth engine: Strong demand for TASER devices, body cameras and counter-drone equipment is driving rapid growth in Axon’s hardware and connected-products business. This supports the company’s broader ecosystem of cloud software and public-safety services. Will Strength in Connected Devices Unit Continue to Drive AXON’s Growth?
• Positive Sentiment: Recent earnings and AI capabilities support the bullish case: Axon exceeded quarterly expectations with adjusted EPS of $1.88 versus $1.84 expected and revenue of approximately $904.4 million versus $876.4 million expected. Revenue increased 35.3% year over year, while new AI capabilities could improve the value of Axon’s public-safety platform. Axon Public Safety and New AI Capabilities
• Neutral Sentiment: Technical consolidation follows a sharp advance: AXON had been in a strong uptrend and is now consolidating, leaving investors focused on whether the rally can resume or whether the shares need to reset after their recent gains. Is the Axon Rally Over?
• Negative Sentiment: Valuation is the main pressure point: Analysts note that Axon’s strong growth is already reflected in the stock price. With a very high price-to-earnings ratio, even solid results may not be enough to sustain upward momentum, prompting some investors to downgrade the shares or take profits. Axon Q2 Was Strong but Valuation Concerns Remain
• Negative Sentiment: Insider selling adds a modest sentiment headwind: CEO Patrick Smith sold 9,930 shares for approximately $5.45 million under a pre-arranged Rule 10b5-1 plan. The sale represented only about 0.33% of his holdings, so it is not a major change in insider ownership but may reinforce profit-taking concerns.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of recent research reports. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. UBS Group upped their price objective on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. raised their price objective on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Piper Sandler boosted their target price on shares of Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $730.92.

Insider Buying and Selling

In related news, President Joshua Isner sold 13,000 shares of the stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the transaction, the president directly owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This represents a 7.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. The trade was a 2.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 68,989 shares of company stock worth $36,016,932 over the last ninety days. 4.20% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.